We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JWN
451
DELISTED
Nordstrom
JWN
$2.4M 0.03%
40,215
+6,291
+19% +$360K
STAA icon
452
STAAR Surgical
STAA
$1.14B
$2.4M 0.03%
50,000
-35,000
-41% -$1.43M
ACHN
453
DELISTED
Achillion Pharmaceuticals
ACHN
$2.39M 0.03%
650,000
CCL icon
454
Carnival Corporation Ltd
CCL
$37.1B
$2.39M 0.03%
37,475
-13,628
-27% -$827K
NSU
455
DELISTED
Nevsun Resources Ltd.
NSU
$2.38M 0.03%
+537,300
New +$2.06M
ADM icon
456
Archer Daniels Midland
ADM
$40.1B
$2.36M 0.03%
47,025
-4,625
-9% -$227K
IQV icon
457
IQVIA
IQV
$35.6B
$2.36M 0.03%
18,158
-3,289
-15% -$395K
DOV icon
458
Dover
DOV
$27.7B
$2.35M 0.03%
26,571
-5,159
-16% -$426K
MEOH icon
459
Methanex
MEOH
$4.19B
$2.32M 0.03%
29,462
+7,466
+34% +$543K
SVU
460
DELISTED
SUPERVALU Inc.
SVU
$2.32M 0.03%
+71,869
New +$2.1M
XRAY icon
461
Dentsply Sirona
XRAY
$2.61B
$2.3M 0.03%
60,838
+1,042
+2% +$43.4K
LNC icon
462
Lincoln National
LNC
$7.88B
$2.29M 0.03%
33,830
-48,971
-59% -$3.23M
CMS icon
463
CMS Energy
CMS
$22.9B
$2.29M 0.03%
46,697
-26,540
-36% -$1.29M
AEE icon
464
Ameren
AEE
$31B
$2.29M 0.03%
36,158
+32,281
+833% +$2.03M
SRE icon
465
Sempra
SRE
$59.7B
$2.28M 0.03%
40,012
-454
-1% -$26.3K
LPNT
466
DELISTED
LifePoint Health, Inc.
LPNT
$2.25M 0.03%
35,000
+26,000
+289% +$1.58M
VVC
467
DELISTED
Vectren Corporation
VVC
$2.25M 0.03%
+31,500
New +$2.25M
CORI
468
DELISTED
Corium International, Inc.
CORI
$2.24M 0.03%
236,000
+40,000
+20% +$345K
LVS icon
469
Las Vegas Sands
LVS
$31.6B
$2.23M 0.03%
37,530
-88,408
-70% -$5.94M
RNAC icon
470
Cartesian Therapeutics
RNAC
$229M
$2.22M 0.03%
4,767
MTD icon
471
Mettler-Toledo International
MTD
$27B
$2.21M 0.03%
3,625
+46
+1% +$27.1K
BBY icon
472
Best Buy
BBY
$18.6B
$2.2M 0.03%
27,766
-1,663
-6% -$129K
CNC icon
473
Centene
CNC
$31.6B
$2.2M 0.03%
30,380
-3,882
-11% -$270K
RSG icon
474
Republic Services
RSG
$66.7B
$2.2M 0.03%
30,231
-5,397
-15% -$391K
XEL icon
475
Xcel Energy
XEL
$50.4B
$2.19M 0.03%
46,430
+26
+0.1% +$1.23K

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.